BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Paediatrics, Adult Health, New Business, and Other. The Paediatrics segment cultures an ingredient in a licensee's product and royalties from paediatric health products. The Adult Health segment includes digestive health tablets, oral health tablets, cultures as an ingredient in a licensee's dairy products. The other segment consists of animal health products. The company was founded by Jan Annwall and Peter Rothschild in 1990 and is headquartered in Stockholm, Sweden.